Background: Traditional Chinese medicine (TCM) is widely used among
Chinese cancer patients. However, little is known about Chinese patientsâ
expectations and barriers toward using TCM for cancer. Methods: We
conducted a cross-sectional survey within a patient-support group, the Beijing
Anti-Cancer Association. We measured the outcome, Chinese cancer survivorsâ
expectations and barriers toward TCM utilization, using a modified version of
ABCAM (Attitudes and Beliefs towards Complementary and Alternative Medicine),
the ABTCM (Attitudes and Beliefs towards Traditional Chinese Medicine). We used
multivariate models to evaluate the impact of socioeconomic status and clinical
factors on their expectations and barriers (including treatment concerns and
logistical challenges domain) toward TCM. Results: Among 590
participants, most patients expected TCM to boost their immune system (96%),
improve their physical health (96%), and reduce symptoms (94%). Many had
logistical challenges (difficulty decocting herbs (58%) and finding a good TCM
physician (55%)). A few were concerned that TCM might interfere with
conventional treatments (7.6%), and that many TCM treatments are not based on
scientific research (9.1%). In the multivariable regression model, age â€60 years
was independently associated with higher expectation score (P =
.031). Age â€60 years (coefficient 5.0, P = .003) and localized
disease (coefficient 9.5, P = .001) were both associated with
higher treatment concerns. Active employment status (coefficient 9.0,
P = .008) and localized disease (coefficient 7.5,
P = .030) were related to more logistical challenges.
Conclusion: Age and cancer stage were related to Chinese cancer
patientsâ perceived expectations and barriers toward TCM use. Understanding
these attitudes is important for reshaping the role that TCM plays in Chinaâs
patient-centered comprehensive cancer care model.